Recent News

• 11.05.2026 - Oscar Health Announces Financial Results for Third Quarter 2026 and Raises Full Year 2026 Outlook
• 10.20.2026 - Oscar Introduces a New Wave of Consumer Health Products
• 10.12.2026 - Oscar Health, Inc. 2026 Third Quarter Earnings Conference Call
• 04.26.2023 - Oscar Health, Inc. Announces Participation in BofA Securities 2023 Health Care Conference
• 04.19.2023 - Oscar Health Renews and Expands Relationship with Digital Solutions Platform Provider Ciox Health
• 04.13.2023 - Oscar Health, Inc. 2023 First Quarter Conference Call
• 04.11.2023 - Oscar Health, Inc. Releases 2022 Environmental, Social, and Governance (ESG) Report
• 04.05.2023 - Oscar Health, Inc. Announces Inducement Grants under Section 303A.08 of the NYSE Listed Company Manual
• 03.28.2023 - Oscar Health Announces Appointment of Healthcare Veteran Mark Bertolini to CEO; Co-Founder and CEO Mario Schlosser Transitions to President of Technology
• 03.15.2023 - Oscar Health, Inc. Appoints Dr. Sean Martin, MD as New Chief Medical Officer

Recent Filings

• 11.05.2026 - 8-K Current report
• 11.05.2026 - EX-99.1 EX-99.1
• 10.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.18.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 09.18.2026 - 144 Report of proposed sale of securities